Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

32.6%

Threshold

Crossed upwards

Timeline

Published

31.01.2017

Transaction

27.01.2017

Voting rights breakdown

Voting rights acquired32.6%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 4

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBH1U00018

Beneficial owner

Frank-Jan van der Velden 1

Declared address

Frank-Jan van der Velden (1), Echteld

Conditional Right to acquire new shares pursuant to a Combination Agreement entered with Kuros Biosciences AG on 18 December 2016: 1'365'000 shares of Kuros Biosciences Ltd acquired at closing of the Combination Agreement and 740'000 shares of Kuros Biosciences Ltd to be acquired on the achievement of certain product approval milestones. A) Incubation B.V., Bilthoven, controlled by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Person 1 and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Person 2; (B) Aldabra B.V., Amersfoort, the Netherlands, a company controlled by Person 3 and (C) Person 4 shall acquire the shares.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open